Kinin B1 receptors contributes to acute pain following minor surgery in humans

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Hamza, May ^a,e   Wang, Xiao Min ^a   Adam, Albert ^d   Brahim, Jaime S ^b   Rowan, Janet S ^c   Carmona, Gilberto N ^b   Dionne, Raymond A ^a  

^a NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e Ain Shams University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ[1-8]; KALLIDIN[1-9]; KETOROLAC; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; TRAMADOL; VANILLOID RECEPTOR 1; BRADYKININ; MESSENGER RNA; PROSTAGLANDIN SYNTHASE INHIBITOR; TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; MICRODIALYSIS; MINOR SURGERY; MOUTH MUCOSA; PAIN ASSESSMENT; PATHOGENESIS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN INDUCTION; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; TISSUE INJURY; TOOTH EXTRACTION; ACUTE DISEASE; DOWN REGULATION; DRUG EFFECT; GENETICS; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; UPREGULATION;

ACUTE DISEASE; ADOLESCENT; ADULT; BRADYKININ; CYCLOOXYGENASE INHIBITORS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; KETOROLAC; MALE; PAIN, POSTOPERATIVE; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RNA, MESSENGER; TRPV CATION CHANNELS; UP-REGULATION; YOUNG ADULT;

EID: 77949431334     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-6-12     Document Type: Article

References (66)

1. Lee Y-S, Kim H, Brahim JS, Rowan J, Lee G, Dionne RA. Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation. Pain 2007, 129:279-286. 10.1016/j.pain.2006.10.020, 17175104.
2. Wang X, Hamza M, Gordon SM, Wahl SM, Dionne RA. COX inhibitors down-regulate PDE4D expression in a clinical model of inflammatory pain. Clin Pharmacol Ther 2008, 84:39-42. 10.1038/sj.clpt.6100501, 18288087.
3. Wang XM, Wu TX, Hamza M, Ramsay ES, Wahl SM, Dionne RA. Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain 2007, 128:136-147. 10.1016/j.pain.2006.09.011, 1894940, 17070997.
4. Wang X-M, Hamza M, Wu T-X, Dionne RA. Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain. Pain 2009, 142:275-283. 10.1016/j.pain.2009.02.001, 19233564.
5. Swift JQ, Garry MG, Roszkowski MT, Hargreaves KM. Effect of flurbiprofen on tissue levels of immunoreactive bradykinin and acute postoperative pain. J Oral Maxillofac Surg 1993, 51:112-117.
6. Menke JG, Borkowski JA, Bierilo KK, MacNeil T, Derrick AW, Schneck KA, Ransom RW, Strader CD, Linemeyer DL, Hess JF. Expression cloning of a human B1 bradykinin receptor. J Biol Chem 1994, 269:21583-21586.
7. Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun 1992, 184:260-268. 10.1016/0006-291X(92)91187-U, 1314587.
8. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 2005, 99:6-38. 10.1254/jphs.SRJ05001X, 16177542.
9. Ma QP, Heavens R. Basal expression of bradykinin B(1) receptor in the spinal cord in humans and rats. Neuroreport 2001, 12:2311-2314. 10.1097/00001756-200108080-00006, 11496101.
10. Blais C, Marceau F, Rouleau J-L, Adam A. The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides 2000, 21:1903-1940. 10.1016/S0196-9781(00)00348-X, 11150653.
11. Leeb-Lundberg LMF, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005, 57:27-77. 10.1124/pr.57.1.2, 15734727.
12. Phagoo SB, Poole S, Leeb-Lundberg LMF. Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol Pharmacol 1999, 56:325-333.
13. Campos MM, Souza GEP, Calixto JB. Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1[beta] and TNF[alpha]. Peptides 1998, 19:1269-1276. 10.1016/S0196-9781(98)00087-4, 9786178.
14. Fernandes ES, Passos GF, Campos MM, de Souza GEP, Fittipaldi JF, Pesquero JL, Teixeira MM, Calixto JB. Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression. Br J Pharmacol 2005, 146:209-216. 10.1038/sj.bjp.0706327, 1576273, 16025141.
15. Passos GF, Fernandes ES, Campos MM, Araujo JGVC, Pesquero JL, Souza GEP, Avellar MCW, Teixeira MM, Calixto JB. Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx. J Immunol 2004, 172:1839-1847.
16. Levy D, Zochodne DW. Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain 2000, 86:265-271. 10.1016/S0304-3959(00)00256-6, 10812256.
17. Sufka KJ, Roach JT. Stimulus properties and antinociceptive effects of selective bradykinin B1 and B2 receptor antagonists in rats. Pain 1996, 66:99-103. 10.1016/0304-3959(96)02990-9, 8857636.
18. Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA, Walther T, Oliveira SM, Pesquero JL, Paiva ACM, Calixto J, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA 2000, 97:8140-8145. 10.1073/pnas.120035997, 16683, 10859349.
19. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee S-Y, Kim SH, Lee MG, Choi YH, Kim J, et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 2002, 99:10150-10155. 10.1073/pnas.152002699, 126639, 12097645.
20. Lembeck F, Popper H, Juan H. Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect. Naunyn Schmiedebergs Arch Pharmacol 1976, 294:69-73. 10.1007/BF00692786, 1004630.
21. Kumazawa T, Mizumura K. Chemical responses of polymodal receptors of the scrotal contents in dogs. J Physiol 1980, 299:219-231. 1279221, 7381766.
22. Sauer SK, Schäfer D, Kress M, Reeh PW. Stimulated prostaglandin E2 release from rat skin, in vitro. Life Sci 1998, 62:2045-2055. 10.1016/S0024-3205(98)00176-3, 9627103.
23. Averbeck B, Peisler M, Izydorczyk I, Reeh PW. Inflammatory mediators do not stimulate CGRP release if prostaglandin synthesis is blocked by S(+)-flurbiprofen in isolated rat skin. Inflamm Res 2003, 52:519-523. 10.1007/s00011-003-1209-1, 14991081.
24. Pethö G, Derow A, Reeh PW. Bradykinin-induced nociceptor sensitization to heat is mediated by cyclooxygenase products in isolated rat skin. Eur J Neurosci 2001, 14:210-218. 10.1046/j.0953-816x.2001.01651.x, 11553274.
25. Mayer S, Izydorczyk I, Reeh PW, Grubb BD. Bradykinin-induced nociceptor sensitisation to heat depends on COX-1 and COX-2 in isolated rat skin. Pain 2007, 130:14-24. 10.1016/j.pain.2006.10.027, 17196338.
26. Gerdle B, Hilgenfeldt U, Larsson B, Kristiansen J, Søgaard K, Rosendal L. Bradykinin and kallidin levels in the trapezius muscle in patients with work-related trapezius myalgia, in patients with whiplash associated pain, and in healthy controls - A microdialysis study of women. Pain 2008, 139:578-587. 10.1016/j.pain.2008.06.012, 18657364.
27. Marceau F, Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 2004, 3:845-852. 10.1038/nrd1522, 15459675.
28. Bastian S, Loillier B, Paquet JL, Pruneau D. Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization. Br J Pharmacol 1997, 122:393-399. 10.1038/sj.bjp.0701380, 1564937, 9313952.
29. Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2001, 429:161-176. 10.1016/S0014-2999(01)01318-8, 11698039.
30. Regoli D, Marceau F, Barabe J. De novo formation of vascular receptors for bradykinin. Can J Physiol Pharmacol 1978, 56:674-677.
31. Wotherspoon G, Winter J. Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system. Neurosci Lett 2000, 294:175-178. 10.1016/S0304-3940(00)01561-5, 11072143.
32. Phagoo SB, Yaqoob M, Herrera-Martinez E, McIntyre P, Jones C, Burgess GM. Regulation of bradykinin receptor gene expression in human lung fibroblasts. Eur J Pharmacol 2000, 397:237-246. 10.1016/S0014-2999(00)00323-X, 10844120.
33. Larrivee J-F, Bachvarov DR, Houle F, Landry J, Huot J, Marceau F. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. J Immunol 1998, 160:1419-1426.
34. Schanstra JP, Bataille E, Marin Castano ME, Barascud Y, Hirtz C, Pesquero JB, Pecher C, Gauthier F, Girolami JP, Bascands JL. The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J Clin Invest 1998, 101:2080-2091. 10.1172/JCI1359, 508796, 9593764.
35. Pan ZK, Zuraw BL, Lung CC, Prossnitz ER, Browning DD, Ye RD. Bradykinin stimulates NF-κB activation and interleukin 1β gene expression in cultured human fibroblasts. J Clin Invest 1996, 98:2042-2049. 10.1172/JCI119009, 507648, 8903323.
36. Shirasaki H, Kanaizumi E, Himi T. Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa. Mediators Inflamm 2009, 2009:102406. 10.1155/2009/102406, 2673475, 19404481.
37. Brechter AB, Persson E, Lundgren I, Lerner UH. Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-[alpha]. Effects dependent on activation of NF-[kappa]B and MAP kinases. Bone 2008, 43:72-83. 10.1016/j.bone.2008.02.003, 18467203.
38. Dlamini Z, Bhoola KD. Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma. J Clin Pathol 2005, 58:915-922. 10.1136/jcp.2004.021444, 1770819, 16126870.
39. Modéer T, Andurén I, Yucel-Lindberg T. Bradykinin Synergistically Stimulates Interleukin 6 Production in Human Gingival Fibroblasts Challenged with Interleukin 1 or Tumour Necrosis Factor [alpha]. Cytokine 1998, 10:26-31. 10.1006/cyto.1997.0255, 9505142.
40. Brunius G, Domeij H, Gustavsson A, Yucel-Lindberg T. Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha. Regul Pept 2005, 126:183-188. 10.1016/j.regpep.2004.09.005, 15664665.
41. Koyama S, Sato E, Numanami H, Kubo K, Nagai S, Izumi T. Bradykinin Stimulates Lung Fibroblasts to Release Neutrophil and Monocyte Chemotactic Activity. Am J Respir Cell Mol Biol 2000, 22:75-84.
42. Huang CD, Tliba O, Panettieri RA, Amrani Y. Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol 2003, 28:330-338. 10.1165/rcmb.2002-0040OC, 12594059.
43. Wang PH, Cenedeze MA, Campanholle G, Malheiros DM, Torres HA, Pesquero JB, Pacheco-Silva A, Camara NO. Deletion of bradykinin B1 receptor reduces renal fibrosis. Int Immunopharmacol 2009, 9:653-657. 10.1016/j.intimp.2008.10.018, 19010452.
44. Klein J, Gonzalez J, Duchene J, Esposito L, Pradere JP, Neau E, Delage C, Calise D, Ahluwalia A, Carayon P, et al. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. Faseb J 2009, 23:134-142. 10.1096/fj.08-115600, 18809736.
45. Marney AM, Ma J, Luther JM, Ikizler TA, Brown NJ. Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis. J Am Soc Nephrol 2009, 20:2246-2252. 10.1681/ASN.2009050505, 19628666.
46. Dos Santos AC, Roffe E, Arantes RM, Juliano L, Pesquero JL, Pesquero JB, Bader M, Teixeira MM, Carvalho-Tavares J. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. J Neuroinflammation 2008, 5:49. 10.1186/1742-2094-5-49, 2596102, 18986535.
47. Lee CH, Shieh DC, Tzeng CY, Chen CP, Wang SP, Chiu YC, Huang CY, Hsu CJ, Fong YC, Tang CH. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts. Mol Immunol 2008, 45:3693-3702. 10.1016/j.molimm.2008.06.007, 18621420.
48. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824. 10.1038/39807, 9349813.
49. Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, Travers JB. Activation of Epidermal Vanilloid Receptor-1 Induces Release of Proinflammatory Mediators in Human Keratinocytes. Journal of Pharmacology and Experimental Therapeutics 2003, 304:217-222. 10.1124/jpet.102.040675, 12490594.
50. Stander S, Moormann C, Schumacher M, Buddenkotte J, Artuc M, Shpacovitch V, Brzoska T, Lippert U, Henz BM, Luger TA, et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 2004, 13:129-139. 10.1111/j.0906-6705.2004.0178.x, 14987252.
51. Engler A, Aeschlimann A, Simmen BR, Michel BA, Gay RE, Gay S, Sprott H. Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis. Biochem Biophys Res Commun 2007, 359:884-888. 10.1016/j.bbrc.2007.05.178, 17560936.
52. Miyamoto R, Tokuda M, Sakuta T, Nagaoka S, Torii M. Expression and Characterization of Vanilloid Receptor Subtype 1 in Human Dental Pulp Cell Cultures. Journal of Endodontics 2005, 31:652-658. 10.1097/01.don.0000155259.22746.ae, 16123700.
53. Reilly CA, Taylor JL, Lanza DL, Carr BA, Crouch DJ, Yost GS. Capsaicinoids Cause Inflammation and Epithelial Cell Death through Activation of Vanilloid Receptors. Toxicol Sci 2003, 73:170-181. 10.1093/toxsci/kfg044, 2423488, 12721390.
54. Veronesi B, Carter JD, Devlin RB, Simon SA, Oortgiesen M. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line. Neuropeptides 1999, 33:447-456. 10.1054/npep.1999.0761, 10657523.
55. Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA. Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 1999, 23:617-624. 10.1016/S0896-6273(00)80813-2, 10433272.
56. Rajpal S, Gerovac TA, Turner NA, Tilghman JI, Allcock BK, McChesney SL, Miranpuri GS, Park SW, Resnick DK. Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats. J Neurosurg Spine 2007, 6:420-424. 10.3171/spi.2007.6.5.420, 17542507.
57. Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther 2006, 109:57-77. 10.1016/j.pharmthera.2005.06.003, 16023729.
58. Katanosaka K, Banik RK, Giron R, Higashi T, Tominaga M, Mizumura K. Contribution of TRPV1 to the bradykinin-evoked nociceptive behavior and excitation of cutaneous sensory neurons. Neurosci Res 2008, 62:168-175. 10.1016/j.neures.2008.08.004, 18789982.
59. Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Earley TJ, Patapoutian A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41:849-857. 10.1016/S0896-6273(04)00150-3, 15046718.
60. Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007, 6:357-372. 10.1038/nrd2280, 17464295.
61. DomBourian MG, Turner NA, Gerovac TA, Vemuganti R, Miranpuri GS, Tureyen K, Satriotomo I, Miletic V, Resnick DK. B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury. Spine 2006, 31:2778-2782. 10.1097/01.brs.0000245865.97424.b4, 17108828.
62. Kanai Y, Nakazato E, Fujiuchi A, Hara T, Imai A. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology 2005, 49:977-984. 10.1016/j.neuropharm.2005.05.003, 15998524.
63. Wang XM, Wu TX, Lee YS, Dionne RA. Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors. Clin Pharmacol Ther 2006, 79:303-315. 10.1016/j.clpt.2005.12.306, 16580899.
64. Raymond P, Drapeau G, Raut R, Audet R, Marceau F, Ong H, Adam A. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods 1995, 180:247-257. 10.1016/0022-1759(94)00320-V, 7714339.
65. Décarie A, Drapeau G, Closset J, Couture R, Adam A. Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides 1994, 15:511-518. 10.1016/0196-9781(94)90214-3, 7937327.
66. Désormeaux A, Moreau ME, Lepage Y, Chanard J, Adam A. The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Biomaterials 2008, 29:1139-1146. 10.1016/j.biomaterials.2007.11.019, 18078988.